Journal article
Contemporary Role of the Decipher® Test in Prostate Cancer Management: Current Practice and Future Perspectives
Reviews in urology, Vol.18(1), pp.1-9
2016
PMCID: PMC4859922
PMID: 27162506
Abstract
We performed a systematic literature search to identify original articles and editorials about the Decipher(®) Prostate Cancer Test (GenomeDx Biosciences, San Diego, CA) to provide an overview of the current literature and its present role in urologic clinical practice. The Decipher test, which uses the expression of 22 selected RNA markers (from a total of over 1.4 million), showed a very high discrimination in predicting clinical metastasis (0.75-0.83) and cancer-specific mortality (0.78) in external validation studies, outperforming all routinely available clinicopathologic characteristics. Further, the timing of postoperative radiotherapy (adjuvant vs salvage) may be guided based on Decipher scores. The Decipher test was also the only independent predictor of clinical metastasis in patients with biochemical recurrence after surgery. The Decipher Genomic Resource Information Database (GRID) is a novel research tool that captures 1.4 million marker expressions per patient and may facilitate precision-guided, individualized care to patients with prostate cancer. In this era of precision medicine, Decipher, along with the Decipher GRID platform, is a promising genomic tool that may aid in managing prostate cancer patients throughout the continuum of care and delivering appropriate treatment at an individualized level.
Details
- Title: Subtitle
- Contemporary Role of the Decipher® Test in Prostate Cancer Management: Current Practice and Future Perspectives
- Creators
- Deepansh Dalela - Henry Ford Health SystemBjörn Löppenberg - Henry Ford Health SystemAkshay Sood - Henry Ford Health SystemJesse Sammon - Henry Ford Health SystemFiras Abdollah - Henry Ford Health System
- Resource Type
- Journal article
- Publication Details
- Reviews in urology, Vol.18(1), pp.1-9
- PMID
- 27162506
- PMCID
- PMC4859922
- NLM abbreviation
- Rev Urol
- ISSN
- 1523-6161
- Language
- English
- Date published
- 2016
- Academic Unit
- Urology
- Record Identifier
- 9984958309402771
Metrics
2 Record Views